1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene decreases expression ISO RGD:1620669 6480464 vinylidene chloride results in decreased expression of ANK2 mRNA CTD PMID:26682919 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317291 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ANK2 mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANK2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317291 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANK2 mRNA CTD PMID:11007951 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3',5'-cyclic AMP multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1620669 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ANK2 mRNA CTD PMID:20188158 3-methylcholanthrene decreases expression ISO RGD:1620669 6480464 Methylcholanthrene results in decreased expression of ANK2 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide decreases expression ISO RGD:1620669 6480464 Fenretinide results in decreased expression of ANK2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ANK2 mRNA CTD PMID:24780913 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1317291 6480464 apocarotenal results in increased expression of ANK2 mRNA CTD PMID:17034753 aflatoxin B1 decreases methylation ISO RGD:1317291 6480464 Aflatoxin B1 results in decreased methylation of ANK2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1317291 6480464 Aflatoxin B1 results in decreased expression of ANK2 mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO RGD:1317291 6480464 Aflatoxin B1 results in increased methylation of ANK2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1317291 6480464 Tretinoin results in decreased expression of ANK2 mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANK2 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1317291 6480464 aristolochic acid I results in decreased expression of ANK2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1317291 6480464 Arsenic affects the methylation of ANK2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1317291 6480464 Arsenic affects the methylation of ANK2 gene CTD PMID:25304211 arsenite(3-) affects expression ISO RGD:1317291 6480464 arsenite affects the expression of ANK2 mRNA CTD PMID:22959463 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ANK2 gene CTD PMID:28931070 avobenzone decreases expression ISO RGD:1317291 6480464 avobenzone results in decreased expression of ANK2 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:1317291 6480464 Benzo(a)pyrene results in decreased expression of ANK2 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene affects methylation ISO RGD:1317291 6480464 Benzo(a)pyrene affects the methylation of ANK2 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1620669 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ANK2 mRNA] CTD PMID:22228805 benzo[e]pyrene increases methylation ISO RGD:1317291 6480464 benzo(e)pyrene results in increased methylation of ANK2 intron CTD PMID:30157460 beta-carotene increases expression ISO RGD:1317291 6480464 beta Carotene results in increased expression of ANK2 mRNA CTD PMID:17034753 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANK2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1620669 6480464 bisphenol A results in decreased expression of ANK2 mRNA CTD PMID:32156529 bisphenol A affects methylation ISO RGD:1317291 6480464 bisphenol A affects the methylation of ANK2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1317291 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ANK2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANK2 mRNA CTD PMID:30816183 bisphenol A decreases methylation ISO RGD:1620669 6480464 bisphenol A results in decreased methylation of ANK2 promoter CTD PMID:27312807 bisphenol A increases expression ISO RGD:1317291 6480464 bisphenol A analog results in increased expression of ANK2 mRNA more ... CTD PMID:29275510 more ... Bisphenol B increases expression ISO RGD:1317291 6480464 bisphenol B results in increased expression of ANK2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1317291 6480464 bisphenol F results in increased expression of ANK2 protein CTD PMID:34186270 butanal decreases expression ISO RGD:1317291 6480464 butyraldehyde results in decreased expression of ANK2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1317291 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANK2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1317291 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANK2 mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO RGD:1317291 6480464 Caffeine affects the phosphorylation of ANK2 protein CTD PMID:35688186 carmustine affects response to substance ISO RGD:1317291 6480464 ANK2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 choline multiple interactions ISO RGD:1620669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANK2 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ANK2 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1317291 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ANK2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1317291 6480464 Cisplatin results in decreased expression of ANK2 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1317291 6480464 cobaltous chloride results in increased expression of ANK2 mRNA CTD PMID:19376846 cycloheximide multiple interactions ISO RGD:1317291 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ANK2 mRNA] CTD PMID:11007951 cyclosporin A increases expression ISO RGD:1317291 6480464 Cyclosporine results in increased expression of ANK2 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:1317291 6480464 Cyclosporine results in decreased expression of ANK2 mRNA CTD PMID:25562108 daunorubicin decreases expression ISO RGD:1317291 6480464 Daunorubicin results in decreased expression of ANK2 mRNA CTD PMID:26537877 , PMID:28940058 dioxygen decreases expression ISO RGD:1317291 6480464 Oxygen deficiency results in decreased expression of ANK2 mRNA CTD PMID:24236059 dioxygen increases expression ISO RGD:1620669 6480464 Oxygen deficiency results in increased expression of ANK2 mRNA CTD PMID:24205000 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ANK2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1317291 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1317291 6480464 Doxorubicin results in decreased expression of ANK2 mRNA CTD PMID:26537877 more ... endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ANK2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1317291 6480464 entinostat results in increased expression of ANK2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1317291 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK2 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1620669 6480464 Ethanol results in increased expression of ANK2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1620669 6480464 Ethanol affects the expression of and affects the splicing of ANK2 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1317291 6480464 Ethyl Methanesulfonate results in decreased expression of ANK2 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ANK2 mRNA CTD PMID:30307764 folic acid multiple interactions ISO RGD:1620669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANK2 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1317291 6480464 Formaldehyde results in decreased expression of ANK2 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1317291 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ANK2 gene CTD PMID:31601247 genistein increases expression ISO RGD:1620669 6480464 Genistein results in increased expression of ANK2 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANK2 mRNA CTD PMID:33387578 isotretinoin increases expression ISO RGD:1317291 6480464 Isotretinoin results in increased expression of ANK2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1317291 6480464 Ivermectin results in decreased expression of ANK2 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1620669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANK2 mRNA CTD PMID:20938992 lead(0) affects splicing ISO RGD:1317291 6480464 Lead affects the splicing of ANK2 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1317291 6480464 Lead affects the splicing of ANK2 mRNA CTD PMID:28903495 lovastatin decreases response to substance ISO RGD:1317291 6480464 ANK2 SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 methapyrilene increases methylation ISO RGD:1317291 6480464 Methapyrilene results in increased methylation of ANK2 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1317291 6480464 Methyl Methanesulfonate results in decreased expression of ANK2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1317291 6480464 methylmercuric chloride results in decreased expression of ANK2 mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO RGD:1317291 6480464 methylselenic acid results in increased expression of ANK2 mRNA CTD PMID:18548127 mitoxantrone decreases expression ISO RGD:1317291 6480464 Mitoxantrone results in decreased expression of ANK2 mRNA CTD PMID:26537877 , PMID:28940058 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of ANK2 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANK2 mRNA CTD PMID:28801915 O-methyleugenol decreases expression ISO RGD:1317291 6480464 methyleugenol results in decreased expression of ANK2 mRNA CTD PMID:32234424 ozone multiple interactions ISO RGD:1620669 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ANK2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ANK2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1317291 6480464 Acetaminophen results in increased expression of ANK2 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ANK2 mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ANK2 mRNA CTD PMID:32680482 perfluorononanoic acid increases expression ISO RGD:1317291 6480464 perfluoro-n-nonanoic acid results in increased expression of ANK2 mRNA CTD PMID:32588087 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of ANK2 gene CTD PMID:33148267 phenobarbital increases expression ISO RGD:1317291 6480464 Phenobarbital results in increased expression of ANK2 mRNA CTD PMID:19084549 potassium dichromate decreases expression ISO RGD:1620669 6480464 Potassium Dichromate results in decreased expression of ANK2 mRNA CTD PMID:23608068 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of ANK2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:1620669 6480464 Pravastatin results in decreased expression of ANK2 mRNA CTD PMID:27225895 quercetin decreases expression ISO RGD:1317291 6480464 Quercetin results in decreased expression of ANK2 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1317291 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1620669 6480464 Silver results in decreased expression of ANK2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1620669 6480464 Silver results in decreased expression of ANK2 mRNA CTD PMID:27131904 sodium arsenite affects methylation ISO RGD:1317291 6480464 sodium arsenite affects the methylation of ANK2 gene CTD PMID:28589171 sodium arsenite multiple interactions ISO RGD:1317291 6480464 sodium arsenite results in decreased expression of and affects the splicing of ANK2 mRNA CTD PMID:25879800 sulforaphane increases expression ISO RGD:1620669 6480464 sulforaphane results in increased expression of ANK2 mRNA CTD PMID:30529165 sulforaphane increases expression ISO RGD:1317291 6480464 sulforaphane results in increased expression of ANK2 mRNA CTD PMID:31838189 temozolomide affects response to substance ISO RGD:1317291 6480464 ANK2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 thimerosal increases expression ISO RGD:1317291 6480464 Thimerosal results in increased expression of ANK2 mRNA CTD PMID:27188386 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ANK2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1317291 6480464 trichostatin A results in increased expression of ANK2 mRNA CTD PMID:24935251 trichostatin A decreases expression ISO RGD:1317291 6480464 trichostatin A results in decreased expression of ANK2 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1317291 6480464 Triclosan results in decreased expression of ANK2 mRNA CTD PMID:30510588 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1317291 6480464 tris(2-butoxyethyl) phosphate affects the expression of ANK2 mRNA CTD PMID:29024780 tunicamycin increases expression ISO RGD:1620669 6480464 Tunicamycin results in increased expression of ANK2 mRNA CTD PMID:17127020 valproic acid increases expression ISO RGD:1317291 6480464 Valproic Acid results in increased expression of ANK2 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid multiple interactions ISO RGD:1317291 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANK2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1317291 6480464 Valproic Acid results in decreased expression of ANK2 mRNA CTD PMID:23179753 more ... zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of ANK2 mRNA CTD PMID:27225895 zoledronic acid decreases expression ISO RGD:1317291 6480464 zoledronic acid results in decreased expression of ANK2 mRNA CTD PMID:24714768